Cargando…
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs
Recombinant vectors based on human adenovirus serotype 5 (HAdV-5) have been extensively studied in preclinical models and clinical trials over the past two decades. However, the thorough understanding of the HAdV-5 interaction with human subjects has uncovered major concerns about its product applic...
Autores principales: | Alonso-Padilla, Julio, Papp, Tibor, Kaján, Győző L, Benkő, Mária, Havenga, Menzo, Lemckert, Angelique, Harrach, Balázs, Baker, Andrew H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754553/ https://www.ncbi.nlm.nih.gov/pubmed/26478249 http://dx.doi.org/10.1038/mt.2015.194 |
Ejemplares similares
-
Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development
por: Ballmann, Mónika Z., et al.
Publicado: (2021) -
Human adenoviral (HAdV) chronic arthritis expands the infectious spectrum of primary agammaglobulinemia
por: de Frémont, Grégoire Martin, et al.
Publicado: (2022) -
Epidemical features of HAdV-3 and HAdV-7 in pediatric pneumonia in Chongqing, China
por: Wo, Ying, et al.
Publicado: (2014) -
Phylogenetic analysis of all available monkeypox virus strains shows the close relatedness of contemporary ones
por: Benkő, Mária, et al.
Publicado: (2023) -
Human Adenovirus (HAdV) Viremia in Immunocompetent Children with HAdV Infection in Respiratory Specimens: Does Viremia Predict Severity of Illness?
por: Song, Eunkyung, et al.
Publicado: (2017)